- Home
- MOB vs FBIO Comparison
MOB vs FBIO Comparison
Compare MOB & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOB | FBIO |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.0M | 88.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOB | FBIO |
|---|---|---|
| Price | $8.01 | $2.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $10.00 | ★ $16.50 |
| AVG Volume (30 Days) | 335.5K | ★ 337.7K |
| Earning Date | 08-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,826,361.00 | ★ $62,303,000.00 |
| Revenue This Year | $142.38 | $29.71 |
| Revenue Next Year | $99.99 | $49.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.31 | $1.33 |
| 52 Week High | $11.02 | $4.20 |
Technical Indicators
Market Signals| Indicator | MOB | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 59.21 | 56.84 |
| Support Level | $5.88 | $2.49 |
| Resistance Level | $7.56 | $2.86 |
| Average True Range (ATR) | 0.83 | 0.16 |
| MACD | 0.23 | 0.03 |
| Stochastic Oscillator | 91.41 | 90.60 |
Price Performance
Historical ComparisonAbout MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.